Patents by Inventor Stephane Kontos

Stephane Kontos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glycotargeting therapeutics
    Patent number: 11666638
    Abstract: Glycotargeting therapeutics are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: June 6, 2023
    Assignees: Ecole Polytechnique Federale de Lausanne (EPFL), Anokion SA
    Inventors: Jeffrey A. Hubbell, Stephane Kontos, Kristen Marie Lorentz, David Scott Wilson, Shuning Gai
  • Glycotargeting therapeutics
    Patent number: 11654188
    Abstract: Glycotargeting therapeutics are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: May 23, 2023
    Assignees: Ecole Polytechnique Federale de Lausanne (EPFL), Anokion, SA
    Inventors: Jeffrey A. Hubbell, David Scott Wilson, Stephane Kontos, Kristen Marie Lorentz, Shuning Gai
  • GLYCOTARGETING THERAPEUTICS
    Publication number: 20230108299
    Abstract: Glycotargeting therapeutics are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent.
    Type: Application
    Filed: July 1, 2022
    Publication date: April 6, 2023
    Inventors: Jeffrey A. Hubbell, Stephane Kontos, Kristen Marie Lorentz, David Scott Wilson, Shuning Gai
  • Glycotargeting therapeutics
    Patent number: 10821157
    Abstract: Glycotargeting therapeutics are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: November 3, 2020
    Assignees: ANOKION SA, ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (“EPFL”)
    Inventors: Jeffrey A. Hubbell, Stephane Kontos, Kristen Marie Lorentz, David Scott Wilson, Shuning Gai
  • GLYCOTARGETING THERAPEUTICS
    Publication number: 20200121762
    Abstract: Glycotargeting therapeutics are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent.
    Type: Application
    Filed: December 20, 2019
    Publication date: April 23, 2020
    Inventors: Jeffrey A. Hubbell, Stephane Kontos, Kristen Marie Lorentz, David Scott Wilson, Shuning Gai
  • GLYCOTARGETING THERAPEUTICS
    Publication number: 20160015821
    Abstract: Glycotargeting therapeutics are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent.
    Type: Application
    Filed: February 20, 2015
    Publication date: January 21, 2016
    Inventors: Jeffrey A. Hubbell, Stephane Kontos, Kristen Marie Lorentz, David Scott Wilson, Shuning Gai